RESUMEN
INTRODUCTION: The prevalence of alveolar echinococcosis (AE) and cystic echinococcosis (CE) in Germany is increasing. The number of cases in northern and eastern regions is low, so there is little experience with regard to diagnosis and therapy. OBJECTIVES: The objective of this paper was to evaluate the management of suspected and/or diagnosed echinococcosis at a university center in a low-prevalence region. METHODS: All the patients at the Leipzig University Hospital between 2004 and 2018 who had been serologically examined for echinococci were included in a retrospective cohort study. Clinical course, imaging, histology, therapeutic characteristics, relevant comorbidities and risk factors for AE and CE were evaluated. A time-staggered prevalence estimation, as well as sensitivity and specificity calculations for the serological tests, were performed. RESULTS: A total of 382 patients were enrolled, with 11 AE and 7âCE cases identified. The mean prevalence rate of AE in this cohort was 2.9â% and that of CE was 1.8â%. Among the patients, 56â% had known risk factors for AE and CE. The serological tests showed a sensitivity of 86â% and a specificity of 91â%. Two patients with false-negative serology were diagnosed by biopsy. All CE and 5 AE patients (45â%) were operated on. Six AE patients received long-term treatment with albendazole. CONCLUSIONS: AE and CE are rare diseases in the greater Leipzig region; however, case numbers are on the rise. Due to favorable factors such as the escalation of migration, a further increase is expected. Diagnosis and therapy are challenging and should be supported by specialists (experienced infectiologists, imaging experts and skilled hepatobiliary surgeons) who should be integrated in a German network.
Asunto(s)
Equinococosis Pulmonar/epidemiología , Equinococosis/epidemiología , Echinococcus/aislamiento & purificación , Albendazol/uso terapéutico , Animales , Antihelmínticos/uso terapéutico , Equinococosis/diagnóstico , Equinococosis/tratamiento farmacológico , Equinococosis/parasitología , Equinococosis Hepática/diagnóstico , Equinococosis Hepática/tratamiento farmacológico , Equinococosis Hepática/epidemiología , Equinococosis Pulmonar/parasitología , Alemania/epidemiología , Humanos , Enfermedades Desatendidas/diagnóstico , Enfermedades Desatendidas/tratamiento farmacológico , Enfermedades Desatendidas/epidemiología , Prevalencia , Estudios RetrospectivosRESUMEN
Travelers' diarrhea is the most common infectious disease in travel medicine. This article deals with epidemiology, diagnostics, prophylaxis and therapy. The causative pathogens, important differential diagnoses and indications for extended diagnostic measures are discussed in detail. Furthermore, aspects of travel medicine advice as well as the possibilities and limits of infection prevention are presented.